Spyre Therapeutics (SYRE) Q1 2016 Earnings

11MayExpected
Q1 2016
-177.42
-177.09
-176.76
-176.42

Details

Expected EPS
N/A
Actual EPS
-177.4234
Surprise EPS
-177.42
Surprise Percent
+∞%

Description

Spyre Therapeutics (SYRE) has reported earnings of -177.4234 per share for Q1 2016.

0 Comments

Share your thoughts